Cuál es el precio por Hillstream BioPharma, Inc. (HILS)

Precio por Hillstream BioPharma, Inc. (HILS) es de$0.181

Cuál es la capitalización de mercado por Hillstream BioPharma, Inc. (HILS)

Capitalización de mercado por Hillstream BioPharma, Inc. (HILS) es $2.03M

Hillstream BioPharma, Inc. (HILS) Margen Operativo

Hillstream BioPharma, Inc. is a pre-clinical stage biotechnology firm committed to creating groundbreaking therapeutic options. Its core mission is to exploit ferroptosis, an anti-cancer pathway that initiates iron-mediated cell death (IMCD), specifically to address cancers that are resistant to conventional treatments. The company's developmental pipeline features several key candidates: HSB-1216: An IMCD inducer currently under development for solid tumor indications. HSB-888: An IMCD inducer incorporating an anthracycline analogue, delivered via a dual Quatramer system, also aimed at solid tumors. HSB-510: A targeted bifunctional inhibitory compound, encapsulated within the Quatramer delivery system, which demonstrates remarkable potency (single-digit nanomolar IC50) against both PI3K-delta and HDAC6, targets recognized for their role in downregulating cellular processes. HSB-114: An immunotherapeutic agent that leverages the proprietary Quatramer technology to precisely deliver the tumor necrosis factor-alpha gene into cancer cells. Established in 2017, the company's operations are based in Bridgewater, New Jersey.

Año	Margen Operativo	Cambiar
Not enough data for the provided dates.

Año

Margen Operativo

Cambiar

Not enough data for the provided dates.

Empresa	Margen Operativo	Diferencia de Margen Operativo	País
Vertex Pharmaceuticals Incorporated VRTX.US	38.59%	-	US
Argenx SE ARGX.US	28.81%	-	NL
Lonza Group AG LONN.SW	0.00%	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	0.00%	-	KR
UCB S.A. UCB.BR	31.23%	-	BE

Empresa

Margen Operativo

Diferencia de Margen Operativo

País